Oncology/Hematology

Other Cancers

Latest AI and machine learning research in other cancers for healthcare professionals.

8,907 articles
Stay Ahead - Weekly Other Cancers research updates
Subscribe
Browse Categories
Showing 861-880 of 8,907 articles

Deep learning analysis of breast cancer histology predicts ATM pathogenic variant carrier status.

We performed deep learning analysis of histopathological whole-slide (full-face) images (WSI) to predict ATM pathogenic or likely pathogenic variant (PV/LPV) status of women with breast cancer and identify specific histological patterns of their tumor.In the discovery set composed of tumors from PV/LPV carriers (58 WSI) and noncarriers (129 WSI), our deep learning model predicted ATM status of pat...

Jun 15 2026 42298170

Non-invasive imaging diagnostic techniques in metabolic dysfunction-associated steatotic liver disease: a roadmap for clinicians.

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed nonalcoholic fatty liver disease (NAFLD), is the most prevalent chronic liver disorder globally and is strongly associated with obesity, type 2 diabetes mellitus, and the metabolic syndrome. Accurate and timely assessment of hepatic steatosis and fibrosis is critical for risk stratification and therapeutic monitori...

Jun 15 2026 42298258
Proteomics as a Theranostic Compass in BCR::ABL1-Negative Myeloproliferative Neoplasms: Integrating Biomarker Discovery with Therapeutic Stratification.

Classic BCR::ABL1-negative myeloproliferative neoplasms (MPNs)-polycythaemia vera, essential thrombocythaemia, and primary myelofibrosis-are clonal ha...

Jun 14 2026 42289259
A comparative study of machine learning models for microbiome-based diagnosis and multi-class staging of colorectal cancer.

Colorectal cancer (CRC) is closely associated with gut microbiota dysbiosis; however, comprehensive benchmarking of machine learning models that integ...

Jun 14 2026 42289429
Oncotype DX: Clinical Utility, Evidence, and Future Trends in Personalized Breast Cancer Management.

The Oncotype DX assay has revolutionized the management of early-stage, hormone receptor-positive, HER2-negative breast cancer. Developed in 2004, it ...

Jun 14 2026 42290019
ACCURACY OF IMAGE-BASED DEEP LEARNING IN ORAL SQUAMOUS CELL CARCINOMA DIAGNOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS.

OBJECTIVES: The potential of image-based deep learning (DL) in the diagnosis of oral squamous cell carcinoma has been investigated recently. This revi...

Jun 13 2026 42556899
Mitochondrial Metabolic Biomarkers in Periodontitis: Discovery and Clinical Validation.

INTRODUCTION AND AIMS: Mitochondrial metabolic dysregulation is associated with periodontitis (PD); however, related biomarkers remain unclear. In thi...

Jun 13 2026 42288013
Bridging prediction and reality: AI-based external validation of predictive models for lymph node metastasis in gastric cancer.

INTRODUCTION: The optimal extent of lymphadenectomy in gastric cancer surgery remains a subject of ongoing debate. Our previous modelling work indicat...

Jun 12 2026 42341441
Machine Learning-Optimized Single-Atom Catalysts Enable Microenvironment-Adaptive Chemodynamic-Bioorthogonal Cancer Therapy.

Chemodynamic therapy (CDT), which harnesses endogenous chemical energy within the tumor microenvironment (TME), has shown high potential for precise c...

Jun 12 2026 42281521
Cell-specific multi-target mechanisms of cotinine in cervical cancer oncogenesis and progression.

BACKGROUND: Cervical cancer is the fourth most common malignant tumor in women globally, with tobacco smoke being a major environmental risk factor. T...

Jun 12 2026 42283742
Application Value of Radiomics-Based Machine Learning for Preoperative Risk Stratification of Bladder Cancer: Systematic Review and Meta-Analysis.

BACKGROUND: Some researchers have explored the application of radiomics-based machine learning to detect preoperative muscle invasion, high-grade tumo...

Jun 12 2026 42285048
Toward generalizable prediction of cancer signal using a cell-free DNA language model.

Cell-free DNA can be used for early cancer detection, minimal residual disease monitoring, and post-treatment risk stratification. However, current as...

Jun 12 2026 42285091
Molecular Landscape and Advanced Diagnostic Technologies for BRAF Mutations in Cancer: From Quantitative PCR and ddPCR to CRISPR-Based Platforms.

BRAF mutations are key oncogenic alterations across multiple malignancies, including melanoma, thyroid carcinoma, colorectal cancer, non-small cell lu...

Jun 12 2026 42285341
New Frontiers of Skin Ultrasound in Precision Medicine.

Ultrasound has emerged as a versatile, non-invasive imaging technique in dermatology, offering real-time, high-resolution visualization of cutaneous s...

Jun 12 2026 42285862
A multidimensional risk prediction framework for malignant intestinal obstruction based on machine learning: computational model development and clinical validation.

Malignant intestinal obstruction (MIO) is a severe complication of advanced cancer. Traditional static assessment models struggle to capture its dynam...

Jun 12 2026 42286035
Performance of GPT-based large language models in hepatocellular carcinoma stratification: liver function assessment, BCLC staging, and treatment recommendations.

Large language models (LLMs) like GPT have been proposed to support complex clinical decision-making. This study evaluated the performance of GPT-base...

Jun 12 2026 42286178
Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targets.

Acute myeloid leukemia (AML) is a genetically and phenotypically heterogeneous hematological malignancy. Here, to better define this clinically taxing...

Jun 12 2026 42286338
Interpretable machine learning distinguishes skip from continuous metastasis in N1b papillary thyroid carcinoma.

Skip metastasis-defined as lateral lymph node metastasis(N1b) in the absence of central lymph node involvement-represents a distinct yet underrecogniz...

Jun 12 2026 42277367
Innovative strategies to overcome cancer drug resistance: from nanodelivery systems to targeted therapeutics.

Cancer drug resistance, driven by complex genetic mutations, epigenetic plasticity, and tumor microenvironment interactions, remains the primary cause...

Jun 12 2026 42277467
Side-level versus patient-level evaluation in four-view mammography classification: a comprehensive benchmark on the CMMD dataset.

BACKGROUND: Deep learning for mammographic image classification yields impressive performance metrics, but inconsistent evaluation methodologies-speci...

Jun 11 2026 42274080
Browse Categories